Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC